IPHA News
May 3, 2019
Orlaith Brennan, IPHA Director of Commercial Affairs, recently attended the ICHOM annual conference on value based healthcare in Rotterdam. ICHOM is the International Consortium for Healthcare […]
April 26, 2019
On World IP Day, pharmaceutical innovators say it’s vital that the intellectual property (IP) rights that enhance the development of innovative medicines in Europe are protected […]
April 24, 2019
Pharmaceutical Industry Must Be Part of New Government Alliance to Boost Vaccination Rates, Says IPHA On World Immunisation Week, pharmaceutical innovators say it’s vital to take steps […]
April 8, 2019
New data shows Irish patients face growing delays accessing new medicines, ranking well into the bottom half of European countries surveyed as part of a comprehensive […]
March 28, 2019
As the campaign begins ahead of the European Parliament elections on May 24th, the Irish Pharmaceutical Healthcare Association (IPHA) has called on candidates to back progress […]
March 7, 2019
New figures show 10 innovative treatments approved by the HSE for use by patients spent 890 days awaiting decisions The 10 new innovative medicines recently approved […]
February 28, 2019
Just one-third of medicines for rare diseases licensed for patients in Europe are available in Ireland, according to new figures released on Rare Disease Day by […]
February 25, 2019
The Irish Pharmaceutical Healthcare Association (IPHA) has defended the industry against a charge of ‘predatory’ pricing by the National Centre for Pharmoeconomics (NCPE). The NCPE is the […]
February 12, 2019
Ever wondered why Facebook is serving you more and more ads for ways to take better care of health or your video feed features patients telling […]